3.77 Reporting of Race in US FDA Registration Trials with Dr. Mark Lythgoe

Plenary Session

English - May 17, 2021 19:00 - 25 minutes - 21.9 MB - ★★★★★ - 732 ratings
Science Health & Fitness Medicine medicine oncology health policy Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: 3.76 COVID-19 Transmission in Schools with Dr. Christopher Whaley and Dr. Neeraj Sood

Next Episode: 3.78 Astronomy, Being a Scientist, and the Culture of the Academy with Dr. Avi Loeb

Today we talk with Dr. Mark Lythgoe, a Clinical Research Fellow at Imperial College London, on his new paper titled "Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006-2020", out now in Prostate Cancer and Prostatic Diseases.

Race Reporting: doi.org/10.1038/s41391-021-00361-0

Back us on Patreon! www.patreon.com/plenarysession

Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew